Terms: = Ovarian cancer AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Clinical Outcome
2 results:
1. timp-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients.
Mahner S; Woelber L; Eulenburg C; Schwarz J; Carney W; Jaenicke F; Milde-Langosch K; Mueller V
BMC Cancer; 2010 Apr; 10():139. PubMed ID: 20388222
[TBL] [Abstract] [Full Text] [Related]
2. Role of serum-derived hyaluronan-associated protein-hyaluronan complex in ovarian cancer.
Obayashi Y; Yabushita H; Kanyama K; Noguchi M; Zhuo L; Kimata K; Wakatsuki A
Oncol Rep; 2008 May; 19(5):1245-51. PubMed ID: 18425383
[TBL] [Abstract] [Full Text] [Related]
